Compare stocks

Siegfried Holding AG operates in the pharmaceuticals and healthcare industry, specializing in the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company provides comprehensive contract development and manufacturing services to the pharmaceutical industry, including product development, manufacturing, and packaging. Founded in 1873, Siegfried has a long-established history and is headquartered in Zofingen, Switzerland. Its strategic positioning lies in its global manufacturing network, with facilities across Europe, North America, and Asia, which allows it to serve a diverse international client base effectively. The company's competitive strength is enhanced by its integrated service offerings and commitment to quality and innovation in pharmaceutical production.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.